Archive

Latest California Healthline Stories

Qué es el movimiento para “Hacer a América saludable de nuevo” (MAHA)

El regreso de Trump a la Casa Blanca ha dado un nuevo impulso a “Hacer América saludable de nuevo”, un movimiento controversial que desafía las ideas predominantes sobre la salud pública y las enfermedades crónicas.

Georgians With Disabilities Are Still Being Institutionalized, Despite Federal Oversight

For nearly 15 years, the feds have had oversight of Georgia’s treatment of people with mental illness and developmental disabilities. Observers say the state still jeopardizes some of its most marginalized residents by not meeting the terms of its settlement with the Justice Department.

TV’s Dr. Oz Invested in Businesses Regulated by Agency Trump Wants Him To Lead

Celebrity doctor Mehmet Oz recently held broad investments in health care, tech, and food companies. Were he confirmed to run the Centers for Medicare & Medicaid Services, his job would involve interacting with giants of the industry that have contributed to his wealth.

KFF Health News' 'What the Health?': Trump’s Nontraditional Health Picks

Not only has President-elect Donald Trump chosen prominent vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services, Trump also has said he will nominate controversial TV host Mehmet Oz to run the Centers for Medicare & Medicaid Services, which oversees coverage for nearly half of Americans. Meanwhile, the lame-duck Congress is back in Washington with just a few weeks to figure out how to wrap up work for the year. Rachel Cohrs Zhang of Stat, Sandhya Raman of CQ Roll Call, and Riley Ray Griffin of Bloomberg News join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sarah Varney, who has been covering a trial in Idaho challenging the lack of medical exceptions in that state’s abortion ban.

Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval

Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.